PMC:7534795 / 116619-116805 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T657","span":{"begin":86,"end":94},"obj":"Disease"}],"attributes":[{"id":"A657","pred":"mondo_id","subj":"T657","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" due to comorbidities.\n\n9 When and how to intervene with n-3 PUFAs in the context of COVID-19\nAn important aspect in considering n-3 PUFAs as adjunctive therapy in critically or severe "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13949","span":{"begin":62,"end":67},"obj":"Chemical"},{"id":"T75577","span":{"begin":134,"end":139},"obj":"Chemical"}],"attributes":[{"id":"A78563","pred":"chebi_id","subj":"T13949","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A73686","pred":"chebi_id","subj":"T75577","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":" due to comorbidities.\n\n9 When and how to intervene with n-3 PUFAs in the context of COVID-19\nAn important aspect in considering n-3 PUFAs as adjunctive therapy in critically or severe "}

{"project":"LitCovid-sentences","denotations":[{"id":"T710","span":{"begin":24,"end":94},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" due to comorbidities.\n\n9 When and how to intervene with n-3 PUFAs in the context of COVID-19\nAn important aspect in considering n-3 PUFAs as adjunctive therapy in critically or severe "}

{"project":"LitCovid-PubTator","denotations":[{"id":"3333","span":{"begin":86,"end":94},"obj":"Disease"},{"id":"3356","span":{"begin":130,"end":139},"obj":"Chemical"}],"attributes":[{"id":"A3333","pred":"tao:has_database_id","subj":"3333","obj":"MESH:C000657245"},{"id":"A3356","pred":"tao:has_database_id","subj":"3356","obj":"MESH:D015525"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" due to comorbidities.\n\n9 When and how to intervene with n-3 PUFAs in the context of COVID-19\nAn important aspect in considering n-3 PUFAs as adjunctive therapy in critically or severe "}